You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Two new papers have identified thousands of genetic loci with ties to more than two-dozen blood cell traits in individuals from up to five ancestry groups.
New analyses indicate female researchers are publishing less during the coronavirus pandemic than male researchers, according to Nature News.
In Genome Research this week: new tool to identify protein coding sequences, droplet digital PCR-based assay to quantify mitochondrial DNA, and more.
The two genome-wide scores to predict coronary artery disease risk, which were developed using UK Biobank data, were also valid in French-Canadians.
In Science this week: sequencing of neuroblastomas uncovers alterations linked to prognosis, and more.
Researchers were able to identify 40 tumor-specific antigens within two mouse cancer cell lines and seven human primary tumors using this approach.
A meta-analysis of hundreds of thousands of individuals led to several dozen rare or low-frequency variants with relatively pronounced effects on height.
A phylogenetic analysis of gut microbial communities in the Inuit population revealed broad similarities to gut microbiomes from individuals in the city of Montreal.
With a newly sequenced genome for the photosynthetic dinoflagellate Symbiodinium kawagutii, researchers delved into the roots of coral reef endosymbiosis.
The sensor features a DNA-based steric hindrance method, and can detect the presence of antibodies in whole blood in less than 10 minutes.
Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.
A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.
In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.
According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.